Watch FEED. Know when insiders buy.
One email the day a filing lands. Free.
FEED
ENvue Medical, Inc.
3.58
+0.01 +0.28%
USD · close Sep 11
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $39.7MP/E —DIV YIELD —FCF YIELD -29.59%REV TTM $1.9M −17.7%NET INCOME −$21.1MNET DEBT $171K52W 3.57 – 128.40SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $239K | −51.6% | -111.3% | −$5.5M | −$4.9M | — | -1.98 | −$2.7M | $27K | −$2.7M | Aug 17 |
| Q1 2026 · Mar 31 | $653K | −36.3% | -8.4% | −$3.7M | −$3.8M | — | -6.88 | −$4.3M | $17K | −$4.3M | May 18 |
| Q4 2025 · Dec 31derived | $312K | −29.7% | -118.6% | −$14.8M | −$12.9M | — | -20.00 | −$2.7M | $23K | −$2.7M | Apr 15 |
| Q3 2025 · Sep 30 | $722K | +92.0% | 26.2% | −$2.2M | $510K | — | -0.91 | −$2M | $28K | −$2M | Nov 14 |
| Q2 2025 · Jun 30 | $494K | −39.5% | -7.1% | −$4M | −$4M | — | -1.03 | −$3.4M | $4K | −$3.4M | Aug 17 |
| Q1 2025 · Mar 31 | $1M | +11.3% | 36.0% | −$1.9M | −$1.9M | — | -29.90 | −$1.3M | $5K | −$1.3M | May 18 |
| Q4 2024 · Dec 31derived | $444K | −62.3% | 63.7% | −$1.4M | −$1.4M | — | -128.92 | −$548K | $0 | −$548K | Apr 15 |
| Q3 2024 · Sep 30 | $376K | −17.9% | 35.4% | −$970K | −$998K | — | -3.56 | −$836K | $0 | −$836K | Nov 14 |
| Q2 2024 · Jun 30 | $817K | — | 52.4% | −$674K | −$688K | — | -27.18 | −$553K | $2K | −$555K | Aug 19 |
| Q1 2024 · Mar 31 | $921K | — | 72.1% | −$568K | −$588K | — | 2.38 | −$579K | $1K | −$580K | May 20 |
| Q4 2023 · Dec 31derived | $1.2M | — | 62.6% | −$702K | −$813K | — | -21.59 | −$491K | $0 | −$491K | Mar 31 |
| Q3 2023 · Sep 30 | $458K | — | 76.2% | −$670K | −$727K | — | -0.42 | −$682K | $0 | −$682K | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.6M | 6.0% | −$22.9M | −$18.2M | -712.3% | -26.69 | −$9.4M | $60K | −$9.4M | — | — |
| FY2024 · to Dec 31 | $2.6M | 59.0% | −$3.6M | −$3.7M | -144.8% | -137.30 | −$2.5M | $3K | −$2.5M | — | — |
| FY2023 · to Dec 31 | $2.3M | 67.3% | −$3.4M | −$3.7M | -162.5% | -23.32 | −$3.6M | $1K | −$3.6M | — | — |
| FY2022 · to Dec 31 | $752K | 22.2% | −$5M | −$5.4M | -724.5% | -3.84 | −$7M | $3K | −$7M | — | — |
| FY2021 · to Dec 31 | $1.7M | 45.4% | −$5.7M | −$14.3M | -842.6% | -0.57 | −$4.4M | $3K | −$4.4M | — | — |
| FY2020 · to Dec 31 | $623K | 34.3% | −$4.7M | −$4.3M | -694.4% | -0.42 | −$3.4M | $2K | −$3.4M | — | — |
Every number comes from ENvue Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.